Accès ouvert
2024
article
OpenAlex
Eloi Debourdeau, H. Beylerian, Vuong Nguyen, Daniel Barthelmes et autres
Anti-vascular endothelial growth factor (VEGF) is generally given using pro re nata or “treat-and-extend” (T&E) regimens for neovascular age-related macular degeneration (nAMD). Randomized clinical trials have reported that T&E is superior to Pro re nata (PRN), but results from clinical trials may …
fr, au, ch, it, ie, es
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Hemal Mehta, Pierre‐Henry Gabrielle, Yohei Hashimoto, Getiye Dejenu Kibret et autres
PURPOSE: To compare 1-year outcomes of eyes with diabetic macular edema (DME) treated in routine clinical practice based on the proportion of visits where intravitreal VEGF inhibitor injections were delivered. DESIGN: Cohort study. PARTICIPANTS: There were 2288 treatment-naive eyes with DME starting …
au, gb, fr, lb, it, ie, be, ba, nz, ch
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Dumitru Casian, Alexandru Predenciuc, Vasile Culiuc, Joakim Nordanstig et autres
Background: Patient reported outcomes are valuable components in the assessment of results of treatment for peripheral arterial disease (PAD).The aim of the study was to translate the six item Vascular Quality of Life Questionnaire (VascuQoL-6) survey into Romanian, and to validate the …
md, us, se, nz
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Pierre‐Henry Gabrielle, Vuong Nguyen, Louis Arnould, Francesco Viola et autres
PURPOSE: To report the estimated incidence, probability, risk factors, and 1-year outcomes of rhegmatogenous retinal detachment (RRD) in eyes receiving intravitreal injections (IVTs) of VEGF inhibitors for various retinal conditions in routine clinical practice. DESIGN: Retrospective analysis of data from a prospectively …
au, fr, it, us, es, ch, nz, nl, pl
(code pays fourni par la source)
Accès ouvert
2019
article
OpenAlex
Andrzej Belowski, Łukasz Partyka, Marek Krzanowski, Romuald Polczyk et autres
INTRODUCTION Objective clinical assessments should include patient‑reported outcome measures. VascuQol is an established disease‑specific questionnaire assessing the quality of life in patients with peripheral artery disease (PAD). Quality‑of‑life questionnaires require geographical localization and validation. OBJECTIVES The goal of this study was to …
gb, pl, fr, nz
(code pays fourni par la source)
Accès ouvert
2017
article
OpenAlex
Anne Sofie F. Larsen, Anne Therese Reiersen, Morten Jacobsen, Nils‐Einar Kløw et autres
BACKGROUND: The VascuQoL-6 (VQ-6) health-related quality of life questionnaire, a short version of the disease-specific VascuQoL-25, was developed for clinical practice and use in vascular registries. The study purpose was to evaluate the validity and reliability of VQ-6. METHODS: VQ-6 was translated …
no, se, nz
(code pays fourni par la source)
Accès ouvert
2017
article
OpenAlex
Vincent Daïen, Vuong Nguyen, Rohan W. Essex, Nigel Morlet et autres
fr, au, ch
(code pays fourni par la source)
Accès ouvert
2017
article
OpenAlex
Joakim Nordanstig, Monica Pettersson, M. Morgan, Mårten Falkenberg et autres
se, nz
(code pays fourni par la source)
2015
letter
OpenAlex
Paul Fagan, M. Morgan
nz
(code pays fourni par la source)
Accès ouvert
2013
article
OpenAlex
Joakim Nordanstig, Christine Wann‐Hansson, Jan Karlsson, Mats Lundström et autres
se, nz
(code pays fourni par la source)
Accès ouvert
2012
article
OpenAlex
T Beckitt, Jude Day, M. Morgan, P.M. Lamont
gb
(code pays fourni par la source)
Accès ouvert
2010
article
OpenAlex
A. Cobo, Marcos Meseguer, M. Morgan, S. Fortuño et autres
es
(code pays fourni par la source)